These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18780833)

  • 21. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion.
    Rehman A; Tu Y; Arima T; Linsley PS; Flye MW
    Surgery; 1996 Aug; 120(2):205-12. PubMed ID: 8751584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody.
    Vanhove B; Laflamme G; Coulon F; Mougin M; Vusio P; Haspot F; Tiollier J; Soulillou JP
    Blood; 2003 Jul; 102(2):564-70. PubMed ID: 12649149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade.
    Girvin AM; Dal Canto MC; Rhee L; Salomon B; Sharpe A; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(1):136-43. PubMed ID: 10605004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation Blockade.
    Vogel I; Verbinnen B; Van Gool S; Ceuppens JL
    J Immunol; 2016 Jul; 197(2):533-40. PubMed ID: 27288533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro polyclonal activation of conventional T cells with a CD28 superagonist protects mice from acute graft versus host disease.
    Beyersdorf N; Werner S; Wolf N; Hünig T; Kerkau T
    Eur J Immunol; 2015 Jul; 45(7):1997-2007. PubMed ID: 25907100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B7-CD28 interaction promotes proliferation and survival but suppresses differentiation of CD4-CD8- T cells in the thymus.
    Zheng X; Gao JX; Chang X; Wang Y; Liu Y; Wen J; Zhang H; Zhang J; Liu Y; Zheng P
    J Immunol; 2004 Aug; 173(4):2253-61. PubMed ID: 15294937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anergic T cells generated in vitro suppress rejection response to islet allografts.
    Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
    Transplantation; 2000 May; 69(10):2144-8. PubMed ID: 10852614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of CD28 by a synthetical peptoid inhibits T-cell proliferation and attenuates graft-versus-host disease.
    Li N; Zhu F; Gao F; Wang Q; Wang X; Li H; Ma C; Sun W; Xu W; Wang C; Zhang L
    Cell Mol Immunol; 2010 Mar; 7(2):133-42. PubMed ID: 20140006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of mice with a ligand binding blocking anti-CD28 monoclonal antibody improves healing after myocardial infarction.
    Gladow N; Hollmann C; Ramos G; Frantz S; Kerkau T; Beyersdorf N; Hofmann U
    PLoS One; 2020; 15(4):e0227734. PubMed ID: 32298302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell co-signalling molecules in graft-versus-host disease.
    Tanaka J; Asaka M; Imamura M
    Ann Hematol; 2000 Jun; 79(6):283-90. PubMed ID: 10901605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in "human immune system" Rag2(-/-)gammac(-/-) mice.
    Legrand N; Cupedo T; van Lent AU; Ebeli MJ; Weijer K; Hanke T; Spits H
    Blood; 2006 Jul; 108(1):238-45. PubMed ID: 16514056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference.
    Sang W; Zhou C; Cheng N; Li Z; Zeng L; Xu K
    Immunol Lett; 2011 May; 136(2):194-202. PubMed ID: 21277900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
    Tan P; Anasetti C; Hansen JA; Melrose J; Brunvand M; Bradshaw J; Ledbetter JA; Linsley PS
    J Exp Med; 1993 Jan; 177(1):165-73. PubMed ID: 7678111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maturation of neonatal human CD4 T cells: III. Role of B7 co-stimulation at priming.
    Yang LP; Demeure CE; Byun DG; Vezzio N; Delespesse G
    Int Immunol; 1995 Dec; 7(12):1987-93. PubMed ID: 8746568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limited density of an antigen presented by RMA-S cells requires B7-1/CD28 signaling to enhance T-cell immunity at the effector phase.
    Li XL; Sluijter M; Doorduijn EM; Kale SP; McFerrin H; Liu YY; Li Y; Mottamal M; Yao X; Du F; Gu B; Hoang K; Nguyen YH; Taylor N; Stephens CR; van Hall T; Zhang QJ
    PLoS One; 2014; 9(11):e108192. PubMed ID: 25383875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. During acute graft versus host disease CD28 deletion in donor CD8
    Uri A; Lühder F; Kerkau T; Beyersdorf N
    Eur J Immunol; 2018 Dec; 48(12):2055-2067. PubMed ID: 30320878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway.
    Ndejembi MP; Teijaro JR; Patke DS; Bingaman AW; Chandok MR; Azimzadeh A; Nadler SG; Farber DL
    J Immunol; 2006 Dec; 177(11):7698-706. PubMed ID: 17114440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD7 and CD28 are required for murine CD4+CD25+ regulatory T cell homeostasis and prevention of thyroiditis.
    Sempowski GD; Cross SJ; Heinly CS; Scearce RM; Haynes BF
    J Immunol; 2004 Jan; 172(2):787-94. PubMed ID: 14707048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.